Novelrad is a forward-thinking brand that has developed a micro sewing machine revolutionizing the field of suturing. With just a simple click of a button, their versatile suturing platform can deploy a range of continuous suture patterns percutaneously, mimicking the surgical ‘gold standard’. This groundbreaking technology is not limited to cardiovascular procedures but can also address multiple indications beyond the cardiovascular field.

Novelrad's solutions include a Transcatheter Continuous Sutures MIS platform and a VCD solution for minimally invasive suturing for vascular and heart defect closure. They have also developed a percutaneous suturing device for closing vascular access sites following catheterization procedures, ensuring safe dilation and reliable closure. The team behind Novelrad consists of experienced professionals with extensive knowledge in medical device development.

Led by Netanel Sharabani, co-founder and CEO, their team has expertise in research and development, operations, quality, and regulatory affairs. With their dedication to innovation, Novelrad is shaping the future of suturing technology. Connect with them today to experience their cutting-edge solutions